JPS5953499A - デスオキシウリジン誘導体、その製造法および医薬 - Google Patents

デスオキシウリジン誘導体、その製造法および医薬

Info

Publication number
JPS5953499A
JPS5953499A JP58150111A JP15011183A JPS5953499A JP S5953499 A JPS5953499 A JP S5953499A JP 58150111 A JP58150111 A JP 58150111A JP 15011183 A JP15011183 A JP 15011183A JP S5953499 A JPS5953499 A JP S5953499A
Authority
JP
Japan
Prior art keywords
compound
acid addition
pyrimidine
formula
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58150111A
Other languages
English (en)
Japanese (ja)
Inventor
ハ−フリ−ト・グリ−ングル
エ−リツヒ・バネツク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of JPS5953499A publication Critical patent/JPS5953499A/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
JP58150111A 1982-08-17 1983-08-16 デスオキシウリジン誘導体、その製造法および医薬 Pending JPS5953499A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4922/82 1982-08-17
CH492282 1982-08-17

Publications (1)

Publication Number Publication Date
JPS5953499A true JPS5953499A (ja) 1984-03-28

Family

ID=4284858

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58150111A Pending JPS5953499A (ja) 1982-08-17 1983-08-16 デスオキシウリジン誘導体、その製造法および医薬

Country Status (16)

Country Link
JP (1) JPS5953499A (es)
AU (1) AU1800483A (es)
BE (1) BE897516A (es)
DE (1) DE3390162T1 (es)
DK (1) DK372283A (es)
ES (1) ES8604943A1 (es)
FI (1) FI832884A7 (es)
FR (1) FR2531962B1 (es)
GB (1) GB2125401B (es)
IL (1) IL69497A0 (es)
IT (1) IT1169765B (es)
NL (1) NL8302859A (es)
PT (1) PT77209B (es)
SE (1) SE8304408L (es)
WO (1) WO1984000759A1 (es)
ZA (1) ZA836072B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
SE8605503D0 (sv) * 1986-12-19 1986-12-19 Astra Laekemedel Ab Novel medicinal use
US5215971A (en) * 1986-12-19 1993-06-01 Medivir Ab Antiviral pharmaceutical composition comprising 5-substituted pyrimidine nucleosides
US5215970A (en) * 1987-04-16 1993-06-01 Medivir Ab Nucleosides and nucleotide analogues, pharmaceutical composition and processes for the preparation of the compounds
US4863927A (en) * 1987-05-11 1989-09-05 Merck & Co., Inc. 1-(2-hydroxymethyl)cycloalkylmethyl)-5-substituted uracils
US5594124A (en) * 1992-06-22 1997-01-14 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2',2'-difluoropyrimidine nucleosides and 2'-deoxy-2'-fluoropyrimidine nucleosides and intermediates thereof
JPH0673086A (ja) * 1992-06-22 1994-03-15 Eli Lilly & Co 立体選択的な陰イオングリコシル化法
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5606048A (en) * 1992-06-22 1997-02-25 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-Deoxy-2', 2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5401838A (en) * 1992-06-22 1995-03-28 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5426183A (en) * 1992-06-22 1995-06-20 Eli Lilly And Company Catalytic stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides
US5821357A (en) * 1992-06-22 1998-10-13 Eli Lilly And Company Stereoselective glycosylation process for preparing 2'-deoxy-2',2'-difluoropurine and triazole nucleosides
US5424416A (en) * 1993-08-25 1995-06-13 Eli Lilly And Company Process for preparation of 2-deoxy-2,2-difluoro-D-ribofuranosyl-3,5-hydroxy protected-1-alkyl and aryl sulfonates and their use in preparation of 2',2'-difluoro-2'-deoxy nucleosides
SE9701219D0 (sv) * 1997-04-04 1997-04-04 Astra Pharma Prod New compounds
EP1425022A4 (en) * 2001-08-24 2009-04-29 Koronis Pharmaceuticals Inc MUTAGENIC NUCLEOSIDE ANALOGUES FOR THE TREATMENT OF VIRAL DISEASE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3709874A (en) * 1970-03-19 1973-01-09 Syntex Corp 1-beta-d-arabinofuranosyl cytosine derivatives and methods of preparing
GB1601020A (en) * 1978-04-24 1981-10-21 Stichting Grega Vzw 2'-deoxy-5 (2-halogenovinyl)-uridines
GB2060604B (en) * 1979-10-03 1983-11-23 Univ Birmingham And Stichting E15-(2-halogenovinyl)-2'-deoxycytidines
DE3002197A1 (de) * 1980-01-22 1981-07-23 Robugen Gmbh Pharmazeutische Fabrik Esslingen A.N., 7300 Esslingen 5-alkylsubstituierte pyrimidin-nukleoside, verfahren zu deren herstellung und daraus hergestellte virostatische und cytostatische mittel
DE3010399A1 (de) * 1980-03-18 1981-09-24 Kailash Kumar Dr. 2359 Lentföhrden Gauri Verwendung von 5-haloalkyl-pyrimidin-nukleosiden als virostatika und cytostatika
HU183567B (en) * 1981-09-07 1984-05-28 Mta Koezponti Kemiai Kutato In Process for preparing /e/-5-/2-bromo-vinyl/-uridine and derivatives thereof

Also Published As

Publication number Publication date
FI832884L (fi) 1984-02-18
ZA836072B (en) 1985-03-27
FI832884A0 (fi) 1983-08-10
ES524997A0 (es) 1986-02-16
IT1169765B (it) 1987-06-03
IT8322565A0 (it) 1983-08-16
DK372283D0 (da) 1983-08-15
AU1800483A (en) 1984-02-23
BE897516A (fr) 1984-02-13
FI832884A7 (fi) 1984-02-18
DE3390162T1 (de) 1985-02-21
GB2125401B (en) 1985-10-16
SE8304408D0 (sv) 1983-08-15
GB2125401A (en) 1984-03-07
PT77209B (en) 1986-03-18
IL69497A0 (en) 1983-11-30
SE8304408L (sv) 1984-02-18
NL8302859A (nl) 1984-03-16
WO1984000759A1 (fr) 1984-03-01
PT77209A (en) 1983-09-01
DK372283A (da) 1984-02-18
GB8321880D0 (en) 1983-09-14
FR2531962A1 (fr) 1984-02-24
ES8604943A1 (es) 1986-02-16
FR2531962B1 (fr) 1986-11-14

Similar Documents

Publication Publication Date Title
TW205042B (es)
JPS5953499A (ja) デスオキシウリジン誘導体、その製造法および医薬
CA2105112C (en) A process for anomerizing nucleosides
MC1068A1 (fr) Derives de la purine et medicaments qui en contienprocede de preparation de derives de la purine nent
JPH0723394B2 (ja) 新規アデノシン誘導体及び該化合物を有効成分として含有する医薬組成物
CN107629097A (zh) 一种化合物的固体形式及其使用方法
JPS63275598A (ja) デスアザプリン―ヌクレオシド―誘導体
FR2709754A1 (fr) Composés 2' ou 3'-déoxy- et 2', 3'-didéoxy-beta-L-pentofuranonucléosides, procédé de préparation et application thérapeutique, notamment anti-virale.
JPH01153698A (ja) 2’,3’−ジデオキシ−2’−フルオローヌクレオシド
JPH06507644A (ja) 抗癌剤としての2’−フルオロ−2−置換アデニニルアラビノシド
Uenishi et al. Syntheses and antitumor activities of D-and L-2′-deoxy-4′-thio pyrimidine nucleosides
AU684604B2 (en) Monohydrate of (E)-2'-deoxy-2'-(fluoromethylene)cytidine
DE60107832T2 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
JPH0240369A (ja) 新規なネプラノシン誘導体類
JPH05247078A (ja) 糖化合物、シアル酸含有糖鎖類生合成阻害剤、その製造方法、並びに新規な中間体
JPH02104586A (ja) ピリミジン誘導体及びその使用
Hall Riboside Derivatives of 6-Methyl-asym-triazine-3, 5 (2, 4)-dione1
Sivapriya et al. New conformationally locked thioderivatives of mannose: synthesis, applications, and mechanistic studies
CN106317147B (zh) 核苷类化合物及其制备方法
JP4211901B2 (ja) 4’−メチルヌクレオシド化合物
Yamashita et al. An efficient synthesis of novel deoxy phospha sugar pyrimidine nucleosides
Groziak et al. Definitive Solution Structures for the 6-Formylated Versions of 1-(βD-Ribofuranosyl)-, 1-(2′-Deoxy-β-D-Ribofuranosyl)-, and 1-β-D-Arabinofuranosyluracil, and of Thymidine
Winkley et al. Pyrimidine nucleosides. III. Nucleoside derivatives of certain 4-substituted-6-pyrimidinones
US4992427A (en) 2-substituted inosines and their use as antiviral agents
SU961354A1 (ru) 3-Фтор-2,3-дидезоксиаденозин,про вл ющий цитостатическую активность